Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nune Markosyan

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Endocrinology|September 27, 2008
Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicleNune Markosyan, Diane M Duffy
Oncoimmunology|August 13, 2014
Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillanceNune Markosyan, Edward P Chen, Emer M Smyth
Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2012
Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid raftsSalam Ibrahim, Ann McCartney, Nune Markosyan, et al.
Frontiers in Pharmacology|September 27, 2021
Editorial: Eicosanoids in CancerNune Markosyan, Emer M Smyth, Paola Patrignani, et al.
Biology of Reproduction|September 1, 2006
Primate granulosa cell response via prostaglandin E2 receptors increases late in the periovulatory intervalNune Markosyan, Brandy L Dozier, Frank A Lattanzio, et al.
Reproduction (Cambridge, England)|February 18, 2015
Estrogen promotes luteolysis by redistributing prostaglandin F2α receptors within primate luteal cellsSoon Ok Kim, Nune Markosyan, Gerald J Pepe, et al.
Breast Cancer Research : BCR|September 6, 2013
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activityNune Markosyan, Edward P Chen, Rebecca A Evans, et al.
Carcinogenesis|March 5, 2014
Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte functionEdward P Chen, Nune Markosyan, Emma Connolly, et al.
Research Square|June 30, 2025
CD40 agonism enhances immune checkpoint blockade and generates immunologic memory via CD4<sup>+</sup> T cells in ERα+ mammary tumorsCasey Lam, Olivia Lanchoney, Vishnu Maddipatla, et al.
Carcinogenesis|July 21, 2011
Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumorsNune Markosyan, Edward P Chen, Victoire N Ndong, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Endocrinology|September 27, 2008
Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicleNune Markosyan, Diane M Duffy
Oncoimmunology|August 13, 2014
Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillanceNune Markosyan, Edward P Chen, Emer M Smyth
Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2012
Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid raftsSalam Ibrahim, Ann McCartney, Nune Markosyan, et al.
Frontiers in Pharmacology|September 27, 2021
Editorial: Eicosanoids in CancerNune Markosyan, Emer M Smyth, Paola Patrignani, et al.
Biology of Reproduction|September 1, 2006
Primate granulosa cell response via prostaglandin E2 receptors increases late in the periovulatory intervalNune Markosyan, Brandy L Dozier, Frank A Lattanzio, et al.
Reproduction (Cambridge, England)|February 18, 2015
Estrogen promotes luteolysis by redistributing prostaglandin F2α receptors within primate luteal cellsSoon Ok Kim, Nune Markosyan, Gerald J Pepe, et al.
Breast Cancer Research : BCR|September 6, 2013
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activityNune Markosyan, Edward P Chen, Rebecca A Evans, et al.
Carcinogenesis|March 5, 2014
Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte functionEdward P Chen, Nune Markosyan, Emma Connolly, et al.
Research Square|June 30, 2025
CD40 agonism enhances immune checkpoint blockade and generates immunologic memory via CD4<sup>+</sup> T cells in ERα+ mammary tumorsCasey Lam, Olivia Lanchoney, Vishnu Maddipatla, et al.
Carcinogenesis|July 21, 2011
Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumorsNune Markosyan, Edward P Chen, Victoire N Ndong, et al.
Pageof 2